News und Analysen
STAAR Surgical Provides COVID-19 Business Update
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided a business update relating to
MEDICREA Reports 2019 Annual Results and 2020 First Quarter Sales
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
Lantheus Holdings, Inc. Reports Preliminary Q1 Revenue Near Top End of Previously Disclosed Guidance Range; Withdraws 2020 Financial Guidance
Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus” or the “Company”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of
Simulations Plus Partners with Large Pharmaceutical Company to Enhance High-Throughput PBPK Capabilities in ADMET Predictor®
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that
NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced preliminary operational and financial results for the
Simulations Plus Sets Date for 2nd Quarter 2020 Earnings Release and Conference Call
Simulations Plus, Inc. (Nasdaq: SLP) announced today that it expects to file its quarterly report on Form 10-Q for the second quarter of its 2020 fiscal year, the period ended February 29, 2020, on
Simulations Plus Acquires Lixoft, Expanding Modeling Software Offerings and Broadening Presence in Europe
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, today announced that it has acquired Lixoft of Paris
Good News bei... Eckert & Ziegler: Rekordgewinn, Dividendenerhöhung und ein Aktiensplit
Drägerwerk: Aktie dank Nachfrageboom im Höhenflug
Drägerwerk (WKN: 555060) erlebt eine Sonderkonjunktur durch die weltweite Ausbreitung des Coronavirus. Die Aktie klettert heute +8,01% auf 95,75 Euro.
Dass die Medizinprodukte jetzt „mehr gebraucht
Simulations Plus Offers Rapid Response COVID-19 Research Initiative
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced the
Drägerwerk: Jetzt mischt Elon Musk mit!
Drägerwerk (WKN: 555060) fertigt die in der Corona-Pandemie in Krankenhäusern so dringend benötigten Beatmungsgeräte. Dazu gab es jüngst einen Großauftrag von der Bundesregierung über 10.000 Geräte
MEDICREA Is Protected From the Consequences of the COVID-19 Pandemic
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
Sandra Suarez-Sharp Joins Simulations Plus to Lead Regulatory Strategies Team
Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that
American Renal Associates Holdings, Inc. Announces Fourth Quarter 2019 Results
American Renal Associates Holdings, Inc. (NYSE: ARA) (the “Company”), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced financial and
Drägerwerk: Die Bundesregierung redet ein großes Wörtchen mit!
Es war der nächste schwarze Montag an den Börsen – eine der ganz wenigen Ausnahmeerscheinungen ist die Aktie von Drägerwerk (WKN: 555060). Der unscheinbare Titel aus dem SDAX ging heute mit einem
Geratherm: Explosion nach Corona-News!
Die explosivsten Wertsteigerungen verzeichnen in Corona-Zeiten Aktien von Unternehmen, deren Präparate oder Produkte zur Eindämmung oder Bekämpfung des COVID-19-Virus dienen. Die heutige News von Ge
Hanger Reports Fourth Quarter 2019 Results and Provides 2020 Outlook
Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced its financial results for the fourth quarter and year ended
American Renal Associates Holdings, Inc. Announces Fourth Quarter 2019 Earnings Release Date and Conference Call
American Renal Associates Holdings, Inc. (NYSE: ARA), a leading kidney care and dialysis provider focused on partnering with local nephrologists, announced today that it will hold its fourth
NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625%
NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that it intends to offer, subject to market conditions and other
NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today reported financial results for the fourth quarter and year ended December 31
Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative
Lantheus and Progenics Agree to Amended Transaction Terms
Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of innovative
NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced ten scientific studies utilizing the GeoMx™ Digital
Lantheus Holdings to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of